Sparrow Pharmaceuticals to Present New Clinical Pharmacology Data on SPI-62 at the 24th European Congress of Endocrinology
Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies for disorders of corticosteroid excess, today announced that it will present new
Davida Katz Kostenloser Wertpapierhandel Mark Mortier Alexis Feinberg European Congress Sparrow Pharmaceuticals
Source: finanznachrichten.de